FDA Orange Book · active-ingredient family
Telavancin hydrochloride
Telavancin hydrochloride is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:VIBATIV · NDA 022110
1
Brand (NDA)
0
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · powder
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| VIBATIVRLD×2 | CUMBERLAND | NDA 022110 | — | Sep 11, 2009 |
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7531623 | Jan 01, 2027 | in 7 mo | Substance |
Telavancin hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
